Genmab A (GMAB) Inventory (2023 - 2026)

Genmab A (GMAB) has reported Inventory for 4 consecutive years, with $18.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory rose 38.46% year-over-year to $18.0 million; the trailing twelve-month figure through Jun 2026 stood at $18.0 million (up 38.46% YoY), and the FY2025 full-year result was $18.0 million, up 100.0% from the prior year.
• Inventory declined to $18.0 million in Q2 2026 per GMAB's latest filing, from $21.0 million in the prior quarter.
• Across five years, Inventory topped out at $21.0 million in Q1 2026 and bottomed at $3.4 million in Q2 2024.
• Historically, Inventory has averaged $11.0 million across 4 years, with a median of $10.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Inventory plunged 39.2% in 2024, then surged 285.74% in 2025.
• Over 4 years, Inventory stood at $9.5 million in 2023, then slumped by 39.2% to $5.8 million in 2024, then jumped by 212.03% to $18.0 million in 2025, then changed by 0.0% to $18.0 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $18.0 million, $21.0 million, and $18.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.